MACRO GROUP PHARMACEUTICALS -MACRO CAPITAL financial statements, including revenue, expenses, profit, and loss

The total revenue of MCRO for the last quarter is 95.72 M EGP, and it's 62.06% lower compared to the previous quarter. The net income of Q2 24 is -10.69 M EGP.